1. United States
2. Wisc.
3. Letter

I am writing as a concerned citizen of Wisconsin to express my deep concern regarding the proposed 15% cap on indirect costs for NIH-funded research. This policy change threatens to undermine the ability of universities and research institutions to sustain high-quality biomedical research, ultimately hindering scientific progress and innovation. Indirect costs cover essential infrastructure, including laboratory maintenance, compliance with federal regulations, and support for core facilities that enable groundbreaking discoveries. Capping these costs at 15% would limit institutions to conduct NIH-funded research, support early-career scientists, and maintain state-of-the-art facilities. States like Wisconsin benefit significantly from NIH-funded research, which not only advances public health but also drives economic growth and job creation. A reduction in institutional support will lead to job losses, hinder medical advancements, and slow down progress in areas such as cancer research, neuroscience, and infectious diseases. I urge you to oppose this indirect cost cap and advocate for a funding structure that ensures the sustainability of scientific research. Continued investment in NIH-funded research is critical to maintaining the United States' leadership in biomedical innovation. Thank you for your time and for your commitment to supporting scientific research. I would welcome the opportunity to discuss this issue further and provide any additional information that may be helpful.